Alfa Cytology

QUICK CONTACT

Alfa Cytology, a research solutions provider, focused on cancer therapeutic development and preclinical studies. From the complex phases of target discovery to IND application, we offer a seamless experience. Alfa Cytology specializes in providing comprehensive and efficient preclinical research services to meet the diverse needs of drug development. Our services include drug efficacy studies, pharmacokinetic studies, drug safety evaluations, etc.

Types of Cancer Targets and Pathways Molecule Types Preclinical Services Resources

Find the Cancer Types

Eye Cancer picture

Eye Cancer

Learn about our research services dedicated to understanding and treating eye cancers, with a focus...

Gynecologic Cancer picture

Gynecologic Cancer

Discover our comprehensive range of services for gynecologic cancer research, offering advanced...

Head and Neck Cancer picture

Head and Neck Cancer

Learn about our cutting-edge solutions for studying and combating head and neck cancers, providing...

Lung Cancer picture

Lung Cancer

Explore our research services focused on understanding and addressing lung cancers...

Skin Cancer picture

Skin Cancer

Discover our expertise in skin cancer research, offering advanced diagnostic tools, molecular...

Bladder Cancer picture

Bladder Cancer

Learn how our comprehensive range of services can support bladder cancer research, providing valuable...

Blood Cancer picture

Blood Cancer

Discover our specialized services tailored to studying cancers of the lymphatic system and blood...

Sarcomas picture

Sarcomas

Learn about our cutting-edge solutions for studying and combating bone and soft tissue cancers...

Brain and Nervous System Cancer picture

Brain and Nervous System Cancer

Explore our services focused on understanding and addressing brain and nervous system cancers...

Breast Cancer picture

Breast Cancer

Learn how our comprehensive range of services can support breast cancer research, from biomarker discovery...

Gastrointestinal Cancer picture

Gastrointestinal Cancer

Discover our expertise in gastrointestinal cancer research, providing valuable insights into...

Thyroid Cancer picture

Thyroid Cancer

Explore our specialized services for studying thyroid cancer, including hormone-based therapies...

About Us

Alfa Cytology, based in New York, USA, is a research solutions provider, focused on cancer therapeutic development and preclinical studies.

Scientific Excellence

Customized Solutions

Collaborative Approach

Data
Security

Find the Targets and Pathways

Immune Checkpoint Inhibitors

We specialize in developing therapies that target immune checkpoints, such as PD-1, PD-L1, and CTLA-4, to enhance the body's immune response to cancer cells.

Cancer Growth Inhibitors

Our services focus on the development of growth inhibitors to disrupt cancer cell growth pathways, e.g., CDK, VEGF-VEGFR, PI3K/AKT/mTOR pathway, PARP, and disrupt tumor cell survival.

Cytokine and Chemokine Pathway Inhibitors

Our company is dedicated to the development of cytokine and chemokine pathway inhibitors that inhibit angiogenesis and interfere with tumor cell metabolism, e.g., inhibition of TNF-α, IL-1, IL-6, chemokine receptors, etc.

Protein Kinase Inhibitors

We offer expertise in developing inhibitors that target specific protein kinases implicated in cancer, e.g., EGFR, HER2, ALK .

Cancer Stem Cells Inhibitors

Our company focuses on the development of tumor stem cell inhibitors, with a particular focus on key signaling pathway inhibitors such as Notch and Wnt.

TAM Modulators

Our company is deeply engaged in the research field of TAM modulator, especially in the three key targets of AXL, MER and TYRO3.

NK Modulators

In our company's scientific research, the study of NK modulators has been at the core of our research, especially on a series of key targets such as NKG2D, NKp30, NKp44, NKp46, NKG2A, and KIR.

IAP Inhibitors

IAP Inhibitors research has always been at the core of our company's research, and we have focused on the in-depth study of key targets such as XIAP, cIAP1, and the NF-κB pathway.

Autophagy Inhibitors

In the field of autophagy modulator research, our company has a deep professional background and unique technical advantages, with a special focus on key targets such as VPS34, ATG, mTOR and Beclin 1.

Find the Molecule Types

Small Molecule picture

Small Molecule

Our services encompass target identification, lead optimization, medicinal chemistry, and preclinical evaluation of small molecule drugs.

Therapeutic Antibody picture

Therapeutic Antibody

Our services include antibody discovery, engineering, optimization, and production, with the aim of developing targeted and immunotherapeutic approaches to cancer treatment.

Cell Therapy picture

Cell Therapy

Our expertise lies in the development and optimization of cell therapies, contributing to the advancement of personalized and immunotherapeutic strategies against cancer.

Gene Therapy picture

Gene Therapy

Our services cover gene delivery systems, gene editing technologies, and the development of viral vectors to enable precise and targeted interventions in cancer cells.

Cancer Vaccine picture

Cancer Vaccine

Our services encompass antigen selection, vaccine design, and immunogenicity evaluation, contributing to the development of preventive and therapeutic cancer vaccines.

Peptide Therapeutics picture

Peptide Therapeutics

Our expertise includes peptide design, synthesis, modification, and pharmacological evaluation, enabling the development of tailored and targeted peptide therapeutics.

Find the Service Types

Cancer Basic Research Services

Alfa Cytology offers foundational insights into cancer's biological processes and mechanisms.

Cancer Diagnostic Development Services

These services focus on developing advanced cancer diagnostic tools and technologies.

Cancer Modeling Services

Cancer Modeling ServicesUtilizing in vivo and in vitro models to understand cancer progression.

Cancer Drug Development Services

Alfa Cytology provides advanced cancer drug development services for oncology research and innovation.

Preclinical Research Services

Alfa Cytology is a leading provider of comprehensive preclinical research services, offering innovative solutions to support medical breakthroughs.

Explore Our Resources

About Alfa Cytology

As a committed preclinical research service provider focused on cancer, Alfa Ctytology’s one-stop drug discovery services and a range of technology platforms will address the diverse needs of our clients, guaranteeing innovative and effective research results.

Designing Your Preclinical Cancer Modeling Mouse Studies

As a committed preclinical research service provider focused on cancer, Alfa Ctytology’s one-stop drug discovery services and a range of technology platforms will address the diverse needs of our clients, guaranteeing innovative and effective research results.

Single B Cell Technology for Antibody Discovery

Alfa Cytology offers Single B Cell Technology, a cutting-edge platform for the discovery of antibodies, enabling the identification and development of highly specific and effective therapeutic antibodies.

High-Throughput Screening (HTS) Platform for Pancreatic Cancer Drug Discovery

Alfa Cytology offers a cutting-edge High-Throughput Screening (HTS) platform to accelerate the discovery and development of new drugs for pancreatic cancer treatment, enabling researchers to efficiently identify promising therapeutic candidates.

Innovative ADC Therapeutics Development for Breast Cancer

Alfa Cytology specializes in the development of innovative antibody-drug conjugates (ADCs) for breast cancer therapies, leveraging the specificity of monoclonal antibodies and the potency of cytotoxic drugs.

PARP Inhibitor Development Based on PDX Models

PARP inhibitors are a groundbreaking cancer therapy significantly improved by PDX models, which reliably replicate tumor characteristics and drug responses, with Alfa Cytology specializing in custom PDX models for PARP inhibitor development.

Important Links

Contact Us

Get In Touch

Alfa Cytology, a preclinical research solution provider, provides its clients with one-stop solutions to accelerate cancer therapeutics discovery and development.

Copyright © 2025 Alfa Cytology. All rights reserved.